Entecavir
- Product NDC
- 51407-065
- 11-digit product format
- 514070065
- Labeler code
- 51407
- Product ID
- 51407-065_c59b16ba-f58b-3b00-e053-2a95a90aec96
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Entecavir
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA205824
- Marketing category
- ANDA
- Marketing start
- 2017-08-25
- Marketing end
- 2022-04-30
- Substance
- ENTECAVIR
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-065-30 | 51407006530 | 30 TABLET, FILM COATED in 1 BOTTLE (51407-065-30) | 2018-05-16 | 0000-00-00 | No | No | Current |